Clinical Trial Update: Allogeneic Stem Cell Transplant for CLL [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia and related diseases has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia
• Richter Syndrome

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-02-10